JLE

Epileptic Disorders

MENU

Identifying patients with epilepsy at high risk of cardiac death: signs, risk factors and initial management of high risk of cardiac death Volume 23, issue 1, February 2021

  • [1] Blümcke I., Arzimanoglou A., Beniczky S., Wiebe S. Roadmap for a competency–based educational curriculum in epileptology: report of the Epilepsy Education Task Force of the International League Against Epilepsy. Epileptic Disord. 2019;21:129-140.
  • [2] Neligan A., Bell G.S., Johnson A.L., Goodridge D.M., Shorvon S.D., Sander J.W. The long–term risk of premature mortality in people with epilepsy. Brain. 2011;134:388-395.
  • [3] Olesen J.B., Abildstrøm S.Z., Erdal J., Gislason G.H., Weeke P., Andersson C. Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study. Pharmacoepidemiol Drug Saf. 2011;20:964-971.
  • [4] Janszky I., Hallqvist J., Tomson T., Ahlbom A., Mukamal K.J., Ahnve S. Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy––the Stockholm Heart Epidemiology Program. Brain. 2009;132:2798-2804.
  • [5] Bardai A., Lamberts R.J., Blom M.T., Spanjaart A.M., Berdowski J., van der Staal S.R. Epilepsy is a risk factor for sudden cardiac arrest in the general population. PLoS One. 2012;7:e42749.
  • [6] Lamberts R.J., Blom M.T., Novy J., Belluzzo M., Seldenrijk A., Penninx B.W. Increased prevalence of ECG markers for sudden cardiac arrest in refractory epilepsy. J Neurol Neurosurg Psychiatry. 2015;86:309-313.
  • [7] Keezer M.R., Sisodiya S.M., Sander J.W. Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol. 2016;15:106-115.
  • [8] Shmuely S., van der Lende M., Lamberts R.J., Sander J.W., Thijs R.D. The heart of epilepsy: current views and future concepts. Seizure. 2016;44:176-183.
  • [9] Kobau R., Zahran H., Thurman D.J., Zack M.M., Henry T.R., Schachter S.C. Epilepsy surveillance among adults–19 States. Behavioral Risk Factor Surveillance System, 2005. MMWR Surveill Summ. 2008;57:1-20.
  • [10] Elliott J.O., Moore J.L., Lu B. Health status and behavioral risk factors among persons with epilepsy in Ohio based on the 2006 Behavioral Risk Factor Surveillance System. Epilepsy Behav. 2008;12:434-444.
  • [11] Gaitatzis A, Carroll K, Majeed A, J WS. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004; 45: 1613-22.
  • [12] Vooturi S., Jayalakshmi S. Metabolic syndrome in people with epilepsy. Epilepsy Behav. 2020;106:106992.
  • [13] Verrier R.L., Pang T.D., Nearing B.D., Schachter S.C. The epileptic heart: concept and clinical evidence. Epilepsy Behav. 2020;105:106946.
  • [14] Oduah M.T., Iwanowski P. Cardiovascular complications of epileptic seizures. Epilepsy Behav. 2020;111:107185.
  • [15] Katsiki N., Mikhailidis D.P., Nair D.R. The effects of antiepileptic drugs on vascular risk factors: a narrative review. Seizure. 2014;23:677-684.
  • [16] Bardai A., Blom M.T., van Noord C., Verhamme K.M., Sturkenboom M.C., Tan H.L. Sudden cardiac death is associated both with epilepsy and with use of antiepileptic medications. Heart. 2015;101:17-22.
  • [17] Surges R., Thijs R.D., Tan H.L., Sander J.W. Sudden unexpected death in epilepsy: risk factors and potential pathomechanisms. Nat Rev Neurol. 2009;5:492-504.
  • [18] Surges R., Sander J.W. Sudden unexpected death in epilepsy: mechanisms, prevalence, and prevention. Curr Opin Neurol. 2012;25:201-207.
  • [19] Brigo F., Lochner P., Nardone R., Manganotti P., Lattanzi S. Increased risk of stroke and myocardial infarction in patients with epilepsy: a systematic review of population–based cohort studies. Epilepsy Behav. 2020;104:106307.
  • [20] Van der Lende M., Surges R., Sander J.W., Thijs R.D. Cardiac arrhythmias during or after epileptic seizures. J Neurol Neurosurg Psychiatry. 2016;87:69-74.
  • [21] van Dijk J.G., Thijs R.D., van Zwet E., Tannemaat M.R., van Niekerk J., Benditt D.G. The semiology of tilt–induced reflex syncope in relation to electroencephalographic changes. Brain. 2014;137:576-585.
  • [22] van Dijk J.G., van Rossum I.A., Thijs R.D. Timing of circulatory and neurological events in syncope. Front Cardiovasc Med. 2020;7:36.
  • [23] Wieling W., Thijs R.D., van Dijk N., Wilde A.A., Benditt D.G., van Dijk J.G. Symptoms and signs of syncope: a review of the link between physiology and clinical clues. Brain. 2009;132:2630-2642.
  • [24] Shmuely S., Bauer P.R., van Zwet E.W., van Dijk J.G., Thijs R.D. Differentiating motor phenomena in tilt–induced syncope and convulsive seizures. Neurology. 2018;90:e1339-e1346.
  • [25] Thijs R.D., Wagenaar W.A., Middelkoop H.A., Wieling W., van Dijk J.G. Transient loss of consciousness through the eyes of a witness. Neurology. 2008;71:1713-1718.
  • [26] Thijs R.D., Bloem B.R., van Dijk J.G. Falls, faints, fits and funny turns. J Neurol. 2009;256:155-167.
  • [27] Thijs R.D., Wieling W., van Dijk J.G. Status vasovagalis. Lancet. 2009;373:2222.
  • [28] Kruit M.C., Thijs R.D., Ferrari M.D., Launer L.J., van Buchem M.A., van Dijk J.G. Syncope and orthostatic intolerance increase risk of brain lesions in migraineurs and controls. Neurology. 2013;80:1958-1965.
  • [29] Baumgartner C., Koren J., Britto–Arias M., Schmidt S., Pirker S. Epidemiology and pathophysiology of autonomic seizures: a systematic review. Clin Auton Res. 2019;29:137-150.
  • [30] Devinsky O., Hesdorffer D.C., Thurman D.J., Lhatoo S., Richerson G. Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention. Lancet Neurol. 2016;15:1075-1088.
  • [31] Surges R., Jordan A., Elger C.E. Ictal modulation of cardiac repolarization, but not of heart rate, is lateralized in mesial temporal lobe epilepsy. PLoS One. 2013;8:e64765.
  • [32] Palma J.A., Benarroch E.E. Neural control of the heart: recent concepts and clinical correlations. Neurology. 2014;83:261-271.
  • [33] Chouchou F., Mauguière F., Vallayer O., Catenoix H., Isnard J., Montavont A. How the insula speaks to the heart: cardiac responses to insular stimulation in humans. Hum Brain Mapp. 2019;40:2611-2622.
  • [34] Sevcencu C., Struijk J.J. Autonomic alterations and cardiac changes in epilepsy. Epilepsia. 2010;51:725-737.
  • [35] Eggleston K.S., Olin B.D., Fisher R.S. Ictal tachycardia: the head–heart connection. Seizure. 2014;23:496-505.
  • [36] Jeppesen J, Fuglsang–Frederiksen A, Johansen P, Christensen J, Wüstenhagen S, Tankisi H, et al. Seizure detection using heart rate variability: a prospective validation study. Epilepsia 2020. doi: 10.1111/epi.16511. Epub ahead of print.
  • [37] Lanz M., Oehl B., Brandt A., Schulze–Bonhage A. Seizure induced cardiac asystole in epilepsy patients undergoing long term video–EEG monitoring. Seizure. 2011;20:167-172.
  • [38] Nashef L., So E.L., Ryvlin P., Tomson T. Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia. 2012;53:227-233.
  • [39] Chaila E., Bhangu J., Tirupathi S., Delanty N. Ictal bradycardia and asystole associated with intractable epilepsy: a case series. Br J Cardiol. 2010;17:245-248.
  • [40] Bank A.M., Dworetzky B.A., Lee J.W. Sudden unexpected death in epilepsy in a patient with a cardiac pacemaker. Seizure. 2018;61:38-40.
  • [41] Schuele S.U., Bermeo A.C., Alexopoulos A.V., Locatelli E.R., Burgess R.C., Dinner D.S. Video–electrographic and clinical features in patients with ictal asystole. Neurology. 2007;69:434-441.
  • [42] Hampel K.G., Thijs R.D., Elger C.E., Surges R. Recurrence risk of ictal asystole in epilepsy. Neurology. 2017;89:785-791.
  • [43] Bestawros M., Darbar D., Arain A., Abou–Khalil B., Plummer D., Dupont W.D. Ictal asystole and ictal syncope: insights into clinical management. Circ Arrhythm Electrophysiol. 2015;8:159-164.
  • [44] Kohno R., Abe H., Akamatsu N., Benditt D.G. Long–term follow–up of ictal asystole in temporal lobe epilepsy: is permanent pacemaker therapy needed? J Cardiovasc Electrophysiol. 2016;27:930-936.
  • [45] Strzelczyk A., Cenusa M., Bauer S., Hamer H.M., Mothersill I.W., Grunwald T. Management and long–term outcome in patients presenting with ictal asystole or bradycardia. Epilepsia. 2011;52:1160-1167.
  • [46] Moseley B.D., Ghearing G.R., Munger T.M., Britton J.W. The treatment of ictal asystole with cardiac pacing. Epilepsia. 2011;52:e16-e19.
  • [47] Duplyakov D., Golovina G., Lyukshina N., Surkova E., Elger C.E., Surges R. Syncope, seizure–induced bradycardia and asystole: two cases and review of clinical and pathophysiological features. Seizure. 2014;23:506-511.
  • [48] Jin L., Zhang Y., Wang X.L., Zhang W.J., Liu Y.H., Jiang Z. Postictal apnea as an important mechanism for SUDEP: a near–SUDEP with continuous EEG–ECG–EMG recording. J Clin Neurosci. 2017;43:130-132.
  • [49] Ryvlin P., Nashef L., Lhatoo S.D., Bateman L.M., Bird J., Bleasel A. Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study. Lancet Neurol. 2013;12:966-977.
  • [50] Kim Y., Bravo E., Thirnbeck C.K., Smith–Mellecker L.A., Kim S.H., Gehlbach B.K. Severe peri–ictal respiratory dysfunction is common in Dravet syndrome. J Clin Invest. 2018;128:1141-1153.
  • [51] European Heart Rhythm Association;European Association for Cardio–Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31:2369-429.
  • [52] Desai R., Rupareliya C., Patel U., Naqvi S., Patel S., Lunagariya A. Burden of arrhythmias in epilepsy patients: a nationwide inpatient analysis of 1.4 million hospitalizations in the United States. Cureus. 2017;9:e1550.
  • [53] Surges R., Moskau S., Viebahn B., Schoene–Bake J.C., Schwab J.O., Elger C.E. Prolonged atrial fibrillation following generalized tonic–clonic seizures. Seizure. 2012;21:643-645.
  • [54] Dasheiff R.M., Dickinson L.J. Sudden unexpected death of epileptic patient due to cardiac arrhythmia after seizure. Arch Neurol. 1986;43:194-196.
  • [55] Espinosa P.S., Lee J.W., Tedrow U.B., Bromfield E.B., Dworetzky B.A. Sudden unexpected near death in epilepsy: malignant arrhythmia from a partial seizure. Neurology. 2009;72:1702-1703.
  • [56] Ferlisi M., Tomei R., Carletti M., Moretto G., Zanoni T. Seizure induced ventricular fibrillation: a case of near–SUDEP. Seizure. 2013;22:249-251.
  • [57] Jeppesen J., Fuglsang–Frederiksen A., Brugada R., Pedersen B., Rubboli G., Johansen P. Heart rate variability analysis indicates preictal parasympathetic overdrive preceding seizure–induced cardiac dysrhythmias leading to sudden unexpected death in a patient with epilepsy. Epilepsia. 2014;55:e67-71.
  • [58] Kuttab H.I., Harris E.A., Tataris K.L., Tao J., Beiser D.G. Cardiac arrhythmia following an epileptic seizure. Clin Pract Cases Emerg Med. 2019;3:354-356.
  • [59] Seo M.H., Sung W.Y. A case of near–sudden unexpected death in epilepsy due to ventricular fibrillation. Open Access Emerg Med. 2019;11:161-166.
  • [60] Surges R., Adjei P., Kallis C., Erhuero J., Scott C.A., Bell G.S. Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: a case–control study. Epilepsia. 2010;51:233-242.
  • [61] Surges R., Scott C.A., Walker M.C. Enhanced QT shortening and persistent tachycardia after generalized seizures. Neurology. 2010;74:421-426.
  • [62] Nass R.D., Motloch L.J., Paar V., Lichtenauer M., Baumann J., Zur B. Blood markers of cardiac stress after generalized convulsive seizures. Epilepsia. 2019;60:201-210.
  • [63] Strzelczyk A., Adjei P., Scott C.A., Bauer S., Rosenow F., Walker M.C. Postictal increase in T–wave alternans after generalized tonic–clonic seizures. Epilepsia. 2011;52:2112-2117.
  • [64] Lamberts R.J., Blom M.T., Wassenaar M., Bardai A., Leijten F.S., de Haan G.J. Sudden cardiac arrest in people with epilepsy in the community: circumstances and risk factors. Neurology. 2015;85:212-218.
  • [65] Opherk C., Coromilas J., Hirsch L.J. Heart rate and EKG changes in 102 seizures: analysis of influencing factors. Epilepsy Res. 2002;52:117-127.
  • [66] Tigaran S., Mølgaard H., McClelland R., Dam M., Jaffe A.S. Evidence of cardiac ischemia during seizures in drug refractory epilepsy patients. Neurology. 2003;60:492-495.
  • [67] Pelliccia F., Kaski J.C., Crea F., Camici P.G. Pathophysiology of Takotsubo syndrome. Circulation. 2017;135:2426-2441.
  • [68] Bybee K.A., Prasad A. Stress–related cardiomyopathy syndromes. Circulation. 2008;118:397-409.
  • [69] Sieweke N., Allendörfer J., Franzen W., Feustel A., Reichenberger F., Pabst W. Cardiac Troponin I elevation after epileptic seizure. BMC Neurol. 2012;12:58.
  • [70] Fawaz A., Nasreddine W., Makke Y., Atweh S., Wazne J., Arabi M. Association of cardiovascular risk factors and troponin elevation after generalized tonic–clonic seizures. Seizure. 2014;23:146-150.
  • [71] Chatzikonstantinou A., Ebert A.D., Hennerici M.G. Temporal seizure focus and status epilepticus are associated with high–sensitive troponin I elevation after epileptic seizures. Epilepsy Res. 2015;115:77-80.
  • [72] Nass R.D., Meiling S., Andrié R.P., Elger C.E., Surges R. Laboratory markers of cardiac and metabolic complications after generalized tonic–clonic seizures. BMC Neurol. 2017;17:187.
  • [73] Stöllberger C., Wegner C., Finsterer J. Seizure–associated Takotsubo cardiomyopathy. Epilepsia. 2011;52:e160-e167.
  • [74] Stecker E.C., Reinier K., Uy–Evanado A., Teodorescu C., Chugh H., Gunson K. Relationship between seizure episode and sudden cardiac arrest in patients with epilepsy: a community–based study. Circ Arrhythm Electrophysiol. 2013;6:912-916.
  • [75] Myers K.A., Bello–Espinosa L.E., Symonds J.D., Zuberi S.M., Clegg R., Sadleir L.G. Heart rate variability in epilepsy: a potential biomarker of sudden unexpected death in epilepsy risk. Epilepsia. 2018;59:1372-1380.
  • [76] Myers K.A., Sivathamboo S., Perucca P. Heart rate variability measurement in epilepsy: how can we move from research to clinical practice? Epilepsia. 2018;59:1-10.
  • [77] Suorsa E., Korpelainen J.T., Ansakorpi H., Huikuri H.V., Suorsa V., Myllylä V.V. Heart rate dynamics in temporal lobe epilepsy–a long–term follow–up study. Epilepsy Res. 2011;93:80-83.
  • [78] Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93:1043-1065. Task Force of the European Society of Cardiology, the North American Society of Pacing, Electrophysiology
  • [79] Zack M., Luncheon C. Adults with an epilepsy history, notably those 45-64 years old or at the lowest income levels, more often report heart disease than adults without an epilepsy history. Epilepsy Behav. 2018;86:208-210.
  • [80] Fialho G.L., Wolf P., Walz R., Lin K. Epilepsy and ultra–structural heart changes: the role of catecholaminergic toxicity and myocardial fibrosis. What can we learn from cardiology? Seizure. 2019;71:105-109.
  • [81] Li G., Bauer S., Nowak M., Norwood B., Tackenberg B., Rosenow F. Cytokines and epilepsy. Seizure. 2011;20:249-256.
  • [82] Nass R.D., Zur B., Elger C.E., Holdenrieder S., Surges R. Acute metabolic effects of tonic–clonic seizures. Epilepsia Open. 2019;4:599-608.
  • [83] Devinsky O., Kim A., Friedman D., Bedigian A., Moffatt E., Tseng Z.H. Incidence of cardiac fibrosis in SUDEP and control cases. Neurology. 2018;91:e55-61.
  • [84] Konety S.H., Koene R.J., Norby F.L., Wilsdon T., Alonso A., Siscovick D. Echocardiographic predictors of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study. Circ Cardiovasc Imaging. 2016;9:10.
  • [85] Fialho G.L., Pagani A.G., Wolf P., Walz R., Lin K. Echocardiographic risk markers of sudden death in patients with temporal lobe epilepsy. Epilepsy Res. 2018;140:192-197.
  • [86] Fialho G.L., Wolf P., Walz R., Lin K. Increased cardiac stiffness is associated with autonomic dysfunction in patients with temporal lobe epilepsy. Epilepsia. 2018;59:e85-90.
  • [87] Calik M., Ozkan H.Y., Ethemoglu O., Koca B., Kazanasmaz H., Karacan N. The measurement of both carotid intima–media thickness and epicardial adipose tissue thickness in children with epilepsy receiving antiepileptic drug therapy. Epilepsy Behav. 2018;85:110-114.
  • [88] Tosun O., Karatoprak E. Analysis of tissue Doppler parameters and 24–hour heart rate variations in children with newly diagnosed untreated idiopathic epilepsy in interictal period. Epilepsy Behav. 2019;90:11-14.
  • [89] Li M.C.H., O’Brien T.J., Todaro M., Powell K.L. Acquired cardiac channelopathies in epilepsy: evidence, mechanisms, and clinical significance. Epilepsia. 2019;60:1753-1767.
  • [90] Surges R., Taggart P., Sander J.W., Walker M.C. Too long or too short? New insights into abnormal cardiac repolarization in people with chronic epilepsy and its potential role in sudden unexpected death. Epilepsia. 2010;51:738-744.
  • [91] Drake M.E., Reider C.R., Kay A. Electrocardiography in epilepsy patients without cardiac symptoms. Seizure. 1993;2:63-65.
  • [92] Neufeld G., Lazar J.M., Chari G., Kamran H., Akajagbor E., Salciccioli L. Cardiac repolarization indices in epilepsy patients. Cardiology. 2009;114:255-260.
  • [93] Dogan E.A., Dogan U., Yildiz G.U., Akilli H., Genc E., Genc B.O. Evaluation of cardiac repolarization indices in well–controlled partial epilepsy: 12–Lead ECG findings. Epilepsy Res. 2010;90:157-163.
  • [94] Kishk N.A., Sharaf Y., Ebraheim A.M., Baghdady Y., Alieldin N., Afify A. Interictal cardiac repolarization abnormalities in people with epilepsy. Epilepsy Behav. 2018;79:106-111.
  • [95] Akalin F., Tirtir A., Yilmaz Y. Increased QT dispersion in epileptic children. Acta Paediatr. 2003;92:916-920.
  • [96] Krishnan V., Krishnamurthy K.B. Interictal 12–lead electrocardiography in patients with epilepsy. Epilepsy Behav. 2013;29:240-246.
  • [97] Ramadan M., El–Shahat N., Omar A., Gomaa M., Belal T., Sakr S. Interictal electrocardiographic and echocardiographic changes in patients with generalized tonic–clonic seizures. Int Heart J. 2013;54:171-175.
  • [98] Teh H.S., Tan H.J., Loo C.Y., Raymond A.A. Short QTc in epilepsy patients without cardiac symptoms. Med J Malaysia. 2007;62:104-108.
  • [99] Rejdak K., Rubaj A., Głowniak A., Furmanek K., Kutarski A., Wysokiński A. Analysis of ventricular late potentials in signal–averaged ECG of people with epilepsy. Epilepsia. 2011;52:2118-2124.
  • [100] Verrier R.L., Klingenheben T., Malik M., El–Sherif N., Exner D.V., Hohnloser S.H. Microvolt T–wave alternans: physiologic basis, methods of measurement, and clinical utility. Consensus guideline by the International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol. 2011;44:1309-1324.
  • [101] Verrier R.L., Ikeda T. Ambulatory ECG–based T–wave alternans monitoring for risk assessment and guiding medical therapy: mechanisms and clinical applications. Prog Cardiovasc Dis. 2013;56:172-185.
  • [102] Schomer A.C., Nearing B.D., Schachter S.C., Verrier R.L. Vagus nerve stimulation reduces cardiac electrical instability assessed by quantitative T–wave alternans analysis in patients with drug–resistant focal epilepsy. Epilepsia. 2014;55:1996-2002.
  • [103] Verrier R.L., Nearing B.D., Olin B., Boon P., Schachter S.C. Baseline elevation and reduction in cardiac electrical instability assessed by quantitative T–wave alternans in patients with drug–resistant epilepsy treated with vagus nerve stimulation in the AspireSR E–36 trial. Epilepsy Behav. 2016;62:85-89.
  • [104] Pang T.D., Nearing B.D., Krishnamurthy K.B., Olin B., Schachter S.C., Verrier R.L. Cardiac electrical instability in newly diagnosed/chronic epilepsy tracked by Holter and ECG patch. Neurology. 2019;93:450-458.
  • [105] Libbus I., Nearing B.D., Amurthur B., KenKnight B.H., Verrier R.L. Autonomic regulation therapy suppresses quantitative T–wave alternans and improves baroreflex sensitivity in patients with heart failure enrolled in the ANTHEM–HF study. Heart Rhythm. 2016;13:721-728.
  • [106] Ryvlin P., So E.L., Gordon C.M., Hesdorffer D.C., Sperling M.R., Devinsky O. Long–term surveillance of SUDEP in drug–resistant epilepsy patients treated with VNS therapy. Epilepsia. 2018;59:562-572.
  • [107] Anderson J.H., Bos J.M., Cascino G.D., Ackerman M.J. Prevalence and spectrum of electroencephalogram–identified epileptiform activity among patients with long QT syndrome. Heart Rhythm. 2014;11:53-57.
  • [108] Auerbach D.S., McNitt S., Gross R.A., Zareba W., Dirksen R.T., Moss A.J. Genetic biomarkers for the risk of seizures in long QT syndrome. Neurology. 2016;87:1660-1668.
  • [109] Aurlien D., Leren T.P., Tauboll E., Gjerstad L. New SCN5A mutation in a SUDEP victim with idiopathic epilepsy. Seizure. 2009;18:158-160.
  • [110] Heron S.E., Hernandez M., Edwards C., Edkins E., Jansen F.E., Scheffer I.E. Neonatal seizures and long QT syndrome: a cardiocerebral channelopathy? Epilepsia. 2010;51:293-296.
  • [111] Keller D.I., Grenier J., Christé G., Dubouloz F., Osswald S., Brink M. Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures. Can J Cardiol. 2009;25:455-462.
  • [112] Partemi S., Cestèle S., Pezzella M., Campuzano O., Paravidino R., Pascali V.L. Loss–of–function KCNH2 mutation in a family with long QT syndrome, epilepsy, and sudden death. Epilepsia. 2013;54:e112-e116.
  • [113] Benarroch E.E. HCN channels: function and clinical implications. Neurology. 2013;80:304-310.
  • [114] Lehnart S.E., Mongillo M., Bellinger A., Lindegger N., Chen B.X., Hsueh W. Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J Clin Invest. 2008;118:2230-2245.
  • [115] Ludwig A., Budde T., Stieber J., Moosmang S., Wahl C., Holthoff K. Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2. EMBO J. 2003;22:216-224.
  • [116] Rivolta I., Binda A., Masi A., DiFrancesco J.C. Cardiac and neuronal HCN channelopathies. Pflugers Arch. 2020;472:931-951.
  • [117] Coll M., Striano P., Ferrer–Costa C., Campuzano O., Matés J., Del Olmo B. Targeted next–generation sequencing provides novel clues for associated epilepsy and cardiac conduction disorder/SUDEP. PLoS One. 2017;12:e0189618.
  • [118] Frasier C.R., Wagnon J.L., Bao Y.O., McVeigh L.G., Lopez–Santiago L.F., Meisler M.H. Cardiac arrhythmia in a mouse model of sodium channel SCN8A epileptic encephalopathy. Proc Natl Acad Sci USA. 2016;113:12838-12843.
  • [119] Bagnall R.D., Crompton D.E., Petrovski S., Lam L., Cutmore C., Garry S.I. Exome–based analysis of cardiac arrhythmia, respiratory control, and epilepsy genes in sudden unexpected death in epilepsy. Ann Neurol. 2016;79:522-534.
  • [120] Hookana E., Ansakorpi H., Kortelainen M.L., Junttila M.J., Kaikkonen K.S., Perkiömäki J. Antiepileptic medications and the risk for sudden cardiac death caused by an acute coronary event: a prospective case–control study. Ann Med. 2016;48:111-117.
  • [121] Surges R., Volynski K.E., Walker M.C. Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited. Ther Adv Neurol Disord. 2008;1:13-24.
  • [122] Danielsson B.R., Lansdell K., Patmore L., Tomson T. Phenytoin and phenobarbital inhibit human HERG potassium channels. Epilepsy Res. 2003;55:147-157.
  • [123] Danielsson B.R., Lansdell K., Patmore L., Tomson T. Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents. Epilepsy Res. 2005;63:17-25.
  • [124] Redfern W.S., Carlsson L., Davis A.S., Lynch W.G., MacKenzie I., Palethorpe S. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res. 2003;58:32-45.
  • [125] Auerbach D.S., Biton Y., Polonsky B., McNitt S., Gross R.A., Dirksen R.T. Risk of cardiac events in Long QT syndrome patients when taking antiseizure medications. Transl Res. 2018;191:81-92.e7.
  • [126] Craig S. Phenytoin poisoning. Neurocrit Care. 2005;3:161-170.
  • [127] Degiorgio C.M. Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures. Epilepsy Behav. 2010;18:322-324.
  • [128] DeGiorgio A.C., Desso T.E., Lee L., DeGiorgio C.M. Ventricular tachycardia associated with lacosamide co–medication in drug–resistant epilepsy. Epilepsy Behav Case Rep. 2012;1:26-28.
  • [129] Kaufman K.R., Velez A.E., Wong S., Mani R. Low–dose lacosamide–induced atrial fibrillation: case analysis with literature review. Epilepsy Behav Case Rep. 2012;1:22-25.
  • [130] Hulbert J., Elger C.E., Meyer R., Surges R. Antiepileptic drugs impair shortening of isolated cardiomyocytes. Front Neurol. 2017;8:133.
  • [131] Corbellini ÁB, Torre P.P., Hristova V.N., Sanz B.Z., García A.C.C., Jorge F.R. Cardioembolic acute cerebral micro–infarcts in the context of atrial fibrillation after low–dose intravenous infusion of lacosamide. Epileptic Disord. 2020;22:83-89.
  • [132] Lotufo P.A., Valiengo L., Benseñor I.M., Brunoni A.R. A systematic review and meta–analysis of heart rate variability in epilepsy and antiepileptic drugs. Epilepsia. 2012;53:272-282.
  • [133] Mintzer S., Skidmore C.T., Abidin C.J., Morales M.C., Chervoneva I., Capuzzi D.M. Effects of antiepileptic drugs on lipids, homocysteine, and C–reactive protein. Ann Neurol. 2009;65:448-456.
  • [134] Mintzer S., Yi M., Hegarty S., Maio V., Keith S. Hyperlipidemia in patients newly treated with anticonvulsants: a population study. Epilepsia. 2020;61:259-266.
  • [135] Chuang Y.C., Chuang H.Y., Lin T.K., Chang C.C., Lu C.H., Chang W.N. Effects of long–term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia. 2012;53:120-128.
  • [136] Panebianco M., Zavanone C., Dupont S., Restivo D.A., Pavone A. Vagus nerve stimulation therapy in partial epilepsy: a review. Acta Neurol Belg. 2016;116:241-248.
  • [137] Ghani S., Vilensky J., Turner B., Tubbs R.S., Loukas M. Meta–analysis of vagus nerve stimulation treatment for epilepsy: correlation between device setting parameters and acute response. Childs Nerv Syst. 2015;31:2291-2304.
  • [138] Boon P., Vonck K., van Rijckevorsel K., El Tahry R., Elger C.E., Mullatti N. A prospective, multicenter study of cardiac–based seizure detection to activate vagus nerve stimulation. Seizure. 2015;32:52-61.
  • [139] Kato H., Fujimoto A., Okanishi T., Sugiura R., Ijima K., Enoki H. New onset syncopal events following vagus nerve stimulator implantation might be key to preventing vagus nerve stimulation–induced symptomatic bradycardia – a case report and review. Epilepsy Behav Case Rep. 2018;10:57-60.
  • [140] Kent K.M., Epstein S.E., Cooper T., Jacobowitz D.M. Cholinergic innervation of the canine and human ventricular conducting system. Anatomic and electrophysiologic correlations. Circulation. 1974;50:948-955.
  • [141] Luo S., Michler K., Johnston P., Macfarlane P.W. A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. J Electrocardiol. 2004;37:81-90.
  • [142] Dubin D. Rapid interpretation of EKG's: An interactive course (sixth edition). Tampa, Fla.: Cover Pub. Co., 2000.
  • [143] Verrier R.L., Nearing B.D., Pang T.D., Schachter S.C. Monitoring risk for sudden cardiac death: is there a role for EKG patches? Curr Opin Biomed Eng. 2019;11:117-123.
  • [144] Chua S.K., Chen L.C., Lien L.M., Lo H.M., Liao Z.Y., Chao S.P. Comparison of arrhythmia detection by 24–hour Holter and 14–day continuous electrocardiography patch monitoring. Acta Cardiol Sin. 2020;36:251-259.